tiprankstipranks
Kato (Hong Kong) Holdings Ltd. (HK:2189)
:2189
Hong Kong Market

Kato (Hong Kong) Holdings Ltd. (2189) AI Stock Analysis

1 Followers

Top Page

HK:2189

Kato (Hong Kong) Holdings Ltd.

(2189)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
HK$0.47
▲(3.78% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by weakening financial quality (sharp margin and ROE compression and weaker free cash flow) despite revenue growth and improving leverage. Technical indicators are also soft, while the low P/E and ~4.5% dividend yield meaningfully support the overall score.
Positive Factors
Revenue Growth
Sustained top-line growth (+11.6% in FY2025) reflects rising demand for residential elderly care and stronger occupancy/fee intake. Over a multi-month horizon this supports stable revenue base, capacity utilization, and scalability of care services amid demographic tailwinds.
Negative Factors
Margin Compression
Sharp net margin decline signals meaningful pressure on profitability, potentially from higher operating costs, pricing mix shifts, or one-off changes. Persistently lower margins erode earnings power, reduce reinvestment capacity, and make dividends and returns more sensitive to revenue shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line growth (+11.6% in FY2025) reflects rising demand for residential elderly care and stronger occupancy/fee intake. Over a multi-month horizon this supports stable revenue base, capacity utilization, and scalability of care services amid demographic tailwinds.
Read all positive factors

Kato (Hong Kong) Holdings Ltd. (2189) vs. iShares MSCI Hong Kong ETF (EWH)

Kato (Hong Kong) Holdings Ltd. Business Overview & Revenue Model

Company Description
Kato (Hong Kong) Holdings Limited, an investment holding company, engages in the provision of residential and day care services for the elderly in Hong Kong. The company provides a range of residential care services for the elderly, including acco...

Kato (Hong Kong) Holdings Ltd. Financial Statement Overview

Summary
Revenue grew strongly in FY2025 (+11.6%), leverage improved (debt-to-equity ~0.76), and operating/free cash flow stayed positive. However, profitability and returns deteriorated sharply (net margin ~6.9%, ROE ~5.0%), free cash flow fell materially (-44.5% YoY), and the FY2025 gross margin (~93.6%) is an outlier versus prior years, creating sustainability/comparability risk.
Income Statement
58
Neutral
Balance Sheet
64
Positive
Cash Flow
55
Neutral
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue343.39M317.11M271.33M408.30M320.34M256.53M
Gross Profit109.32M296.85M135.21M185.43M143.75M123.15M
EBITDA119.28M96.84M133.61M206.90M161.67M131.88M
Net Income23.20M21.88M64.19M126.15M98.94M79.87M
Balance Sheet
Total Assets791.44M809.57M863.30M699.30M621.62M602.60M
Cash, Cash Equivalents and Short-Term Investments57.06M52.66M68.71M78.53M58.24M109.12M
Total Debt379.32M332.96M384.30M270.03M294.79M342.05M
Total Liabilities339.75M367.34M428.77M326.36M329.41M369.44M
Stockholders Equity443.73M436.75M434.29M372.63M291.53M232.63M
Cash Flow
Free Cash Flow78.40M71.11M108.10M103.78M42.00M111.80M
Operating Cash Flow101.40M90.89M132.42M159.91M118.98M117.95M
Investing Cash Flow-17.10M9.29M-236.10M-55.89M-75.39M-105.33M
Financing Cash Flow-82.29M-86.55M69.67M-84.02M-93.67M52.25M

Kato (Hong Kong) Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.45
Price Trends
50DMA
0.45
Positive
100DMA
0.45
Positive
200DMA
0.44
Positive
Market Momentum
MACD
<0.01
Negative
RSI
68.40
Neutral
STOCH
70.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2189, the sentiment is Positive. The current price of 0.45 is below the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.45, and above the 200-day MA of 0.44, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 68.40 is Neutral, neither overbought nor oversold. The STOCH value of 70.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2189.

Kato (Hong Kong) Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$356.42M4.984.28%7.10%-2.88%-22.83%
71
Outperform
HK$678.82M3.305.29%9.14%0.47%50.46%
60
Neutral
HK$475.00M4.085.27%4.49%20.85%-66.81%
56
Neutral
HK$545.87M5.0031.63%2.30%
54
Neutral
HK$263.57M-2.55-25.22%3.16%-21.31%-149.92%
52
Neutral
HK$311.23M4.113.54%3.75%9.07%8.95%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.48
0.07
15.85%
HK:1419
Human Health Holdings Ltd.
0.82
0.10
13.89%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.54
-0.59
-52.21%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.21
11.54%
HK:3869
Hospital Corporation of China Ltd
3.95
-2.85
-41.91%
HK:0722
UMP Healthcare Holdings Limited
0.45
0.08
20.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026